CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:The Emerging Role of Extracellular Vesicle-Derived lncRNAs and circRNAs in Tumor and Mesenchymal Stem Cells: The Biological Functions and Potential for Clinical Application.
The Emerging Role of Extracellular Vesicle-Derived lncRNAs and circRNAs in Tumor and Mesenchymal Stem Cells: The Biological Functions and Potential for Clinical Application.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
细胞外囊泡(EVs)几乎由所有类型的细胞释放,它们通过运输生物活性分子(包括蛋白质、DNA、RNA和脂质)在细胞间进行通讯。近年来,EVs携带的RNA,特别是长链非编码RNA(lncRNA)和环状RNA(circRNA)亚型,在控制肿瘤进展方面的作用引起了人们的兴趣。其中,越来越多的报道称间充质干细胞来源的细胞外囊泡(MSC-EVs)维持着新发现的作为lncRNAs和circRNAs运输载体的功能。
然而,目前尚未对MSC-EVs中所含lncRNAs和circRNAs的详细分子功能进行总结,MSC-EVs作为分子载体的效力仍需进一步阐明。本综述总结了EVs的生物学特性以及其中所含lncRNAs和circRNAs的共同机制。重点阐述了EV来源的lncRNAs(EV-lncRNAs)和circRNAs(EV-circRNAs)在不同肿瘤类型与MSCs之间的“双刃剑”效应及相关分子机制。讨论了MSC-EVs在肿瘤诊断和治疗领域的潜力,为工程化MSC-EVs作为抗肿瘤药物载体的策略提出新方向。
Extracellular vesicles (EVs) are released by nearly all types of cells, and they communicate between cells by transporting bioactive molecules, including proteins, DNA, RNA, and lipids. In recent years, RNA carried by EVs, particularly the long-chain non-coding RNA (lncRNA) and circular RNA (circRNA) subtypes, has garnered interest with respect to their role in controlling tumor progression.
Among them, there are increasing reports that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) maintain a recently discovered function as transporters of lncRNAs and circRNAs.
However, detailed molecular functions of lncRNAs and circRNAs contained in MSC-EVs are not presently summarized, and the efficacy of MSC-EVs as molecular carriers requires further elucidation. This review summarizes the biological characteristics of EVs and the common mechanisms of lncRNAs and circRNAs contained within them.
The "double-edged sword" effect and related molecular mechanism of EV-derived lncRNAs (EV-lncRNAs) and circRNAs (EV-circRNAs) between differing tumor types and MSCs are highlighted. The potential of MSC-EVs in the field of tumor diagnosis and treatment is discussed to suggest new directions for the strategy of engineering MSC-EVs as anti-tumor drug carriers.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。